According to the 2019 J.P. Morgan conference playbook released in advance of the investment bank's 37th annual health care meeting in San Francisco, over the past 18 years the NYSE Arca Biotech Index (BTK) outperformed the S&P 500 index approximately 78 percent of the time during event week. With the curtain now closed on the JPM meeting, the public companies involved in the sector will be pleased to learn that this statistic held true for another year.